3-[3-carboxy-2-(2-phenylimidazole-1-carbonyl)benzoyl]-2-(2-phenylimidazole-1-carbonyl)benzoic acid
C35H22N4O7 — CID 21156003
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[3-carboxy-2-(2-phenylimidazole-1-carbonyl)benzoyl]-2-(2-phenylimidazole-1-carbonyl)benzoic acid
3-[3-carboxy-2-(2-phenylimidazole-1-carbonyl)benzoyl]-2-(2-phenylimidazole-1-carbonyl)benzoic acid (PubChem CID 21156003) has the molecular formula C35H22N4O7 and a molecular weight of 610.58 g/mol. Its IUPAC name is 3-[3-carboxy-2-(2-phenylimidazole-1-carbonyl)benzoyl]-2-(2-phenylimidazole-1-carbonyl)benzoic acid.
Molecular Properties
| Compound Name | 3-[3-carboxy-2-(2-phenylimidazole-1-carbonyl)benzoyl]-2-(2-phenylimidazole-1-carbonyl)benzoic acid |
|---|---|
| PubChem CID | 21156003 |
| Molecular Formula | C35H22N4O7 |
| Molecular Weight | 610.58 g/mol |
| Exact Mass | 610.15 |
| IUPAC Name | 3-[3-carboxy-2-(2-phenylimidazole-1-carbonyl)benzoyl]-2-(2-phenylimidazole-1-carbonyl)benzoic acid |
| SMILES | O=C(O)c1cccc(C(=O)c2cccc(C(=O)O)c2C(=O)n2ccnc2-c2ccccc2)c1C(=O)n1ccnc1-c1ccccc1 |
| InChI | InChI=1S/C35H22N4O7/c40-29(23-13-7-15-25(34(43)44)27(23)32(41)38-19-17-36-30(38)21-9-3-1-4-10-21)24-14-8-16-26(35(45)46)28(24)33(42)39-20-18-37-31(39)22-11-5-2-6-12-22/h1-20H,(H,43,44)(H,45,46) |
| InChIKey | AGJFCPZXTMCVLL-UHFFFAOYSA-N |
| XLogP | 5.42 |
| TPSA | 161.45 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 610.58 |
| LogP ≤ 5 | 5.42 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 21156003 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.